Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer

PURPOSE: Cetuximab demonstrates improved efficacy outcomes in patients with metastatic colorectal cancer (mCRC) harboring wild-type KRAS exon 2. Resistance to cetuximab is mediated by activating less frequent mutations in the RAS genes beyond KRAS exon 2. We performed extended RAS Mutational analysi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Kim, Dalyong, Hong, Yong Sang, Kim, Jeong Eun, Kim, Kyu-pyo, Lee, Jae-Lyun, Chun, Sung-Min, Kim, Jihun, Jang, Se Jin, Kim, Tae Won
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266405/
https://ncbi.nlm.nih.gov/pubmed/27121720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados